Reply to the following discussion, no AI, APA style, less than 20 %, plag, 2 or more references. 1.- The correct answer is A. Nehineza, which is least likely to be at risk for developing Osteoporosis, this patient is an overweight African American female with a family history of uterine cancer, is the least likely to be at risk. Research indicates that African American women typically exhibit higher bone mineral density, and increased body weight contributes mechanical loading that helps protect against bone loss. Additionally, her family history of uterine cancer does not directly correlate with an elevated risk for osteoporosis (National Osteoporosis Foundation, 2021). 2. Densitometry results are reported as T-scores. T-scores that fall between -1.0 and -2.5 are classified as indicative of osteopenia, demonstrating a moderate reduction in bone mineral density that does not reach the threshold for osteoporosis (Cosman et al., 2022). Following a prompt analysis of this patient, I have determined the need to initiate treatment for osteoporosis. 3.-The first-line pharmacologic therapy for this condition is bisphosphonates, such as alendronate and risedronate, given their proven efficacy in reducing fracture risk (Eastell et al., 2021). Before starting therapy, it is essential to evaluate the patient for any contraindications, including esophageal abnormalities, hypocalcemia, and renal impairment (McClung & Saag, 2024). Additionally, ensuring adequate intake of calcium and vitamin D is crucial. Patients should be instructed to take bisphosphonates with plain water on an empty stomach and to remain upright for at least 30 minutes to reduce the risk of gastrointestinal irritation (Khan et al., 2023). Renal function should be assessed, as bisphosphonates are contraindicated for patients with a creatinine clearance of less than 30 to 35 mL/min. Laboratory tests should include serum levels of calcium, phosphate, magnesium, and 25-hydroxyvitamin D. Additionally, a dental examination is recommended to check for potential jaw problems before initiating treatment before starting treatment. Baum, S. J. (2023, January 5).
